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binding for the professional, and 
others are binding for both parties.
The European Commission has been 
active in promoting the development 
of Alternative Dispute Resolution as 
a mean to resolve disputes related 
to commercial transactions and 
practices in the EU. In this frame, a 
public consultation on the use of 
alternative dispute resolution (ADR) 
has now been launched.
The purpose is to consult on the 
difficulties identified in relation 
to ADR in the EU and the ways to 
improve it. Stakeholders and public 
authorities are invited to provide their 
feedback on the issues, preferably 
backed with concrete examples 
and/or figures. The consultation 
period runs from 8 January to 5 
March 20.
Alternative Dispute Resolution 
(ADR) schemes, also known as “out-
of-court mechanisms”, have been 
developed across Europe to help 
citizens engaged in a consumer 
dispute who have been unable to 
reach an agreement directly with 
the trader. ADR schemes usually use 
a third party to help the consumer 
and the trader to reach a solution. 
A public consultation on this matter 
has now been launched.
The advantage of ADR is that it offers 
more flexibility than going to court 
and can better meet the needs of 
both consumers and professionals. 
Compared to going to court these 
schemes are cheaper, quicker and 
more informal. 
However, these out-of-court 
mechanisms have been developed 
differently across the European 
Union: some are the fruit of public 
initiatives both at central level and 
at local level, or they may spring 
from private initiatives. Because 
of this diversity, the status of the 
decisions adopted by these bodies 
differs greatly, too. Some are merely 
recommendations, others are only 
Commission launches consultation 
for out-of-court settlement of 
consumer disputes
EU response to the dioxin crisis
in close cooperation with the 
German authorities, the European 
Commission envisages imposing 
a strict separation between the 
production of fats for industrial 
use and fats used to manufacture 
components of animal feed.
The issue of dioxin incident in 
Germany was discussed during 
the Agriculture Council held on 24 
January in Brussels, where Ministers 
assessed the situation with regard 
to the latest developments. After 
having managed the emergency 
2Behavioural study on investment 
decisions
Simpler and standardised product 
information could greatly improve 
EU consumers’ investment decisions, 
according to a Commission behavioural 
study on Consumer Decision-making 
in Retail Investment Services recently 
published.
The study identifies the behavioural traits 
and external factors that most influence 
EU consumers’ investment decisions. This 
analysis is a follow-up to the findings of 
the 2009 Consumer Markets Scoreboard, 
which found the retail investment 
services market to be among the worst 
performing markets for consumers. 
The document will be used to 
complement the future Commission 
consultation on improving the regulation 
of packaged retail investment products, 
in order to better protect consumers 
by making investment products more 
transparent and easier to compare, and 
ensuring effective sales rules.
The full text of the study is available at:
http://ec.europa.eu/consumers/strategy/
docs/final_report_en.pdf
New Europe for Patients website 
now online
The multilingual and thematic website 
of the campaign “Europe for patients” is 
now online with a vibrant new look.
The website is the information hub where 
you can find updated fact-sheets, news, 
events, press releases and videos related 
to the “Europe for Patients” campaign, 
aimed at putting patients at the very 
centre of EU health policy.
The brand new website is available at:
http://ec.europa.eu/health-eu/europe_
for_patients/index_en.htm
In brief
Further information is available at: 
http://europa.eu/rapid/pressReleasesAction.
do?reference=MEMO/ /8&format=HTML&aged=0&l
anguage=EN&guiLanguage=en
“The proper management of 
the dioxin incident in Germany 
is of utmost importance for the 
Commission and must be pursued 
with urgency and effectiveness. My 
services and the German authorities 
are in permanent contact and the 
level of cooperation is very good. 
The Rapid Alert System for Food 
and Feed as well as the traceability 
mechanisms in place at EU level 
have shown their effectiveness. In 
the coming weeks, I will explore with 
our EU partners and stakeholders 
ways to further strengthen our 
monitoring processes of dioxin in 
feed”, Commissioner Dalli declared.
The European Commission is 
closely monitoring the situation 
with the German authorities and 
all relevant information related to 
this contamination incident will be 
immediately transmitted through 
the Rapid Alert System for Food 
and Feed (RASFF). A dedicated 
website has also been created 
regarding this contamination 
incident (http://ec.europa.eu/food/
food/chemicalsafety/contaminants/
dioxin_germany_en.htm).
Commissioner for Health and 
Consumer Policy John Dalli 
announced that the Commission 
is going to present the following 
four concrete measures in the 
upcoming weeks for debate and 
vote in the Standing Committee on 
the Food Chain and Animal Health 
(SCOFCAH):
) The compulsory approval of 
establishments manufacturing, 
treating and marketing fats and fatty 
acids. 
2) The separation/segregation of 
production streams will be examined 
very thoroughly. 
3)      With respect to dioxin monitoring, 
a strict plan for sampling and 
analysis for critical materials in fat 
producing plants will be established. 
It may also be appropriate to cover 
other activities in the feed chain 
by increased monitoring. A dioxin 
data-base, for instance, is already 
established within the European 
Food Safety Authority (EFSA).
4) The extension to private 
laboratories of reporting obligations 
of positive findings could also be 
included in a potential package of 
reinforced dioxin monitoring.
Commission working for safe 
herbal medicines in the EU
The Traditional Herbal Medicinal 
Products Directive of 2004 features a 
7-year transitional period which will 
expire on 30 April 20. But what 
will this mean for manufacturers 
of traditional herbal medicinal 
products?
A traditional herbal medicinal 
product is any medicinal product 
containing as an active ingredient 
herbal substances or herbal 
preparations which can be shown 
to have a traditional use of at least 
30 years, with at least 5 years in the 
European Union. 
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Consultation on potential health 
risks of food resembling chemical 
consumer products
The European Commission and the 
Scientific Committee on Consumer 
Safety (SCCS) have launched a public 
consultation on a scientific opinion on the 
potential health risks posed by chemical 
consumer products resembling food and/
or having child-appealing properties. The 
consultation will run until  February. 
Food-resembling and child-appealing 
chemical consumer products such as 
shower gels, shampoos, body lotions 
and soaps are common on the European 
market. These products resemble items 
of food and appeal to children because 
of their colour, appearance, smell or 
other characteristics. Such products may 
lead to consumers, especially vulnerable 
groups such as young children or the 
elderly, putting them in their mouths and 
swallowing them.
The two main reasons for asking the 
SCCS to assess the risk from accidental 
ingestion of food-resembling and child-
appealing chemical consumer products 
are:
- The difficulty in determining their 
potential health risks due to the large 
number of elements to be taken into 
account. For example, the toxic properties 
of the ingredients and the probability of 
the product being confused with food 
and the amount ingested.
- The need for a common approach in 
the EU to the safety assessment of such 
products.
The draft opinion concludes that there is 
some risk of poisoning, in particular from 
household products. However, the lack of 
specific data on both the frequency and 
effects of accidentally ingesting this kind 
of products means that it is not possible 
to determine the risk level with certainty.
Gathering feedback on the scientific 
evidence and conclusions drawn by the 
SCCS is a key part of the committee’s risk 
assessment procedure. Stakeholders are 
therefore invited to comment through 
this online consultation.
The online consultation is available at:
http://ec.europa.eu/health/scientific_
committees/consultations/public_
consultations/sccs_cons_02_en.htm
In brief
Further information is available at:
http://ec.europa.eu/health/human-use/herbal-medi-
cines/index_en.htm
Examples of herbals used in traditional 
herbal medicinal products include 
Calendula officinalis L; Echinacea 
purpurea L.; Eleutherococcus 
senticosus; Hamamelis virginiana L; 
Mentha x piperita L.
The Traditional Herbal Medicinal 
Products Directive (2004/24/EC) 
was adopted on 3 March 2004. 
It aims to facilitate the placing on 
the EU market of traditional herbal 
medicinal products that despite 
their long tradition were not eligible 
for a full marketing authorisation. It 
also seeks to ensure the protection 
of public health by defining 
guarantees of quality and safety. 
Although such products are natural, 
some can nevertheless provoke 
adverse reactions so they need to be 
covered under EU pharmaceutical 
legislation.
In view of the long tradition 
behind these medicinal products, 
it was decided to provide a special, 
simplified registration procedure. 
The simplified procedure allows 
the registration of traditional 
herbal medicinal products without 
submitting documentation on tests 
and trials on safety and efficacy, 
which the applicant would be obliged 
to provide under the full marketing 
authorisation procedure. Instead, 
the applicant only has to provide 
sufficient evidence of the medicinal 
use of the product throughout a 
period of at least 30 years, including 
at least 5 years in the European 
Union. This procedure is clearly less 
burdensome than the full marketing 
authorisation.  It facilitates the access 
of these products to the EU market, 
while ensuring the safety of herbal 
medicines for EU citizens.
Traditional herbal medicinal products 
that were legally on the market 
before 30 April 2004 were allowed 
to remain on the market without 
complying with the Directive until 
the end of the transitional period. 
This has provided manufacturers 
with a full seven years to submit an 
application for registration. It is now 
up to potential applicants to submit 
their application to the competent 
Member State authorities in good 
time to ensure registration before 
the transitional period expires.
Those initiatives were launched 
during the International Green Week 
in Berlin from 2 to 30 January, and 
will continue taking place, amongst 
others, at the Salon International 
de l’Agriculture in Paris from9 to 
27 February and during the fourth 
edition of the EU Veterinary Week, 
organised in partnership with the 
Federation of Veterinarians of Europe 
(FVE) from 6 May 20.
Vets play a fundamental role in the 
citizens’ daily lives, by being involved 
in the management of heath hazards 
deriving from animal diseases and 
more widely in food safety related 
issues.
On the occasion of The World 
Veterinary Year of 20, which 
marks the 250th birthday of the 
veterinary profession, the European 
Commission’s Directorate-General 
for Health and Consumers (DG 
SANCO) is organizing a series of 
activities to highlight the role of 
“vets in your daily life”: this is the 
slogan for the joint activities of the 
European Commission and the World 
Organisation for Animal Health (OIE), 
aimed at celebrating the anniversary 
and highlighting the diverse role of 
veterinarians across the world.
World Veterinary Year kick-off
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Cross-border healthcare in the EU
On 9 January the European Parliament 
voted in favour of the EU Directive 
on patients’ rights in cross-border 
healthcare. 
“Today’s vote marks an important step 
forward for all patients in Europe”, 
European Commissioner for Health and 
Consumer Policy John Dalli declared. 
“Patients will no longer be left in the dark 
when taking steps to avail of healthcare 
treatments abroad and to get reimbursed 
by their Member State of origin. This 
Directive clarifies the rights of patients, 
which until now have been unclear”, said 
Françoise Grossetête MEP, EP Rapporteur 
on the Directive.
The Directive will benefit patients in 
several ways. It will provide a clear and 
coherent set of rules on cross-border 
healthcare, clarifying the patients’ rights 
to access safe and good quality treatment 
across EU borders, and be reimbursed for 
it. 
It will help patients who need specialised 
treatment, for example those who are 
seeking a diagnosis or treatment for a rare 
disease. Furthermore, the Directive will 
bring about closer and improved health 
cooperation, including the recognition of 
prescriptions, between Member States. 
Health experts across Europe will be able 
to exchange best practices and mutually 
benefit from innovations in health 
technology assessment and eHealth.
“I look forward to a swift implementation 
of this Directive by the Member States”, 
Commissioner Dalli said. Once formally 
adopted by the Council, national 
governments will have indeed 30 months 
to integrate these measures into national 
legislations.
Further information is available at:
h t t p : / / e u r o p a . e u / r a p i d /
p r e s s R e l e a s e s A c t i o n .
do?reference=MEMO// 32&format=H
TML&aged=0&language=EN&guiLangu
age=en
EP news
ND-CV--002-EN-N
The Second International Conference 
on Risk Assessment “Global Risk 
Assessment Dialogue” was organised 
by the European Commission’s 
Directorate-General for Health and 
Consumers from 26 to 28 January 
20 in Brussels.
The Conference aimed at providing 
a Forum for global dialogue on risk 
assessment principles, methods, 
criteria, practices and arrangements 
in the various jurisdictions around 
the world. It was related to and 
builds upon the Transatlantic 
Risk Assessment Dialogue of the 
European Commission with the US 
and Canada. This was the second 
of regular, international bi-annual 
conferences on risk assessment, 
where the first edition took place on 
3-4 November 2008.
The Conference was held over three 
days. The first day focused on the future 
of risk analysis and on consistency 
in risk assessment. The second day 
was organised in five break-out 
sessions, which tackled topics such 
as terminology, uncertainty and 
exposure assessment. The third day 
was dedicated to the first results of 
the dialogue and to the future of the 
global risk assessment dialogue.
Further information is available at:
http://ec.europa.eu/health/risk_assessment/events/
ev_20026_en.htm#fullwidth
Second International Conference 
on Risk Assessment
All the videos are available at:
http://ec.europa.eu/dgs/health_consumer/informa-
tion_sources/videos_ahw_en.htm
During the World Veterinary Year 
20, national veterinary institutions 
will also organise local events to 
raise public awareness about the 
importance of their profession and 
as a reminder that veterinarians 
have been serving humankind for 
250 years.
Amongst the numerous initiatives 
taken, DG SANCO and OIE have 
decided to highlight the wide and 
varied role vets play in our daily lives 
through the production of six videos, 
showcasing the fundamental role of 
vets and their impact on people’s 
life. The videos focus on six major 
themes: animal husbandry, pets, 
crisis management, food security, 
food safety and zoonoses.
Aiming at further strengthening 
the protection of human and 
animal health, the European Union 
earmarked more than €250 million 
to support programmes to eradicate, 
control and monitor animal diseases 
in 20.
For 20, 60 annual or multi-annual 
programmes to eradicate 8 important 
animal diseases will be granted 
Community financial support. 
The total EU contribution to these 
programmes will be around €35 
million. Member States endorsed the 
financial package proposed by the 
European Commission during the 
meeting of the Standing Committee 
on the Food Chain and Animal Health 
(SCoFCAH) of 2 October 200.
Further information is available at:
http://ec.europa.eu/food/animal/diseases/financial/in-
dex_en.htm
Eradication of animal diseases 
programmes for 20
